Kenneth C. Frazier, chairman and chief executive officer of Merck, sat down with Tony Coles, M.D., chairman and chief executive officer of Yumanity Therapeutics and chairman of Cerevel Therapeutics, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback